Novavax

NVAX

NVAX
Novavax Stock Quote
$4.14 -$0.21 -4.8%
BATS BZX Real Time Price as of November 12, 2019, 4:00 p.m. EST View Interactive NVAX Charts

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

News & Analysis: Novavax

The Fool has written over 200 articles on Novavax.

All

Market Moves

Podcasts

Earnings



Why Novavax Is Soaring Today

Investors' optimism about the prospects for the biotech's experimental vaccines appears to be increasing.







Why Novavax Soared Today

The clinical-stage biotech stock appeared to get a bump from three separate reports.


Here's Why Novavax Gained 20.5% in September

A Wall Street analyst turned bullish -- and the market responded in kind. But investors may want to consider the binary nature of this biopharma stock.


Interactive Chart